Safety of Statins

  • Stefano Bellosta
    From the Department of Pharmacological Sciences, University of Milan, Milan, Italy.
  • Rodolfo Paoletti
    From the Department of Pharmacological Sciences, University of Milan, Milan, Italy.
  • Alberto Corsini
    From the Department of Pharmacological Sciences, University of Milan, Milan, Italy.

書誌事項

タイトル別名
  • Focus on Clinical Pharmacokinetics and Drug Interactions

説明

<jats:p>Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The most important adverse effects associated with statins are myopathy and an asymptomatic increase in hepatic transaminases, both of which occur infrequently. Because statins are prescribed on a long-term basis, however, possible interactions with other drugs deserve particular attention, as many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment. This review summarizes the pharmacokinetic properties of statins and emphasizes their clinically relevant drug interactions.</jats:p>

収録刊行物

  • Circulation

    Circulation 109 (23_suppl_1), III50-, 2004-06-15

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ